Enterobiasis In Immunocompromised Patients: An Overlooked Issue
Published on: November 3, 2025
Enterobiasis in Immunocompromised Patients: An Overlooked Issue
Article author photo

Shruti Patil

Bachelor of Pharmacy, Goa University

Article reviewer photo

Ninisha Barman

MPhil Translational Biomedical Research, University of Cambridge

Introduction

Enterobiasis, commonly known as pinworm infection, is a common infection estimated to affect nearly 1 billion people worldwide annually and is caused by white, threadlike-looking parasitic worms called Enterobius vermicularis. Children are usually affected by the pinworm illness, particularly those who live in crowded areas and in impoverished nations. Mostly, the infection is symptomless but may cause a few symptoms such as itching of the anal or vaginal area, insomnia, restlessness, teeth grinding, bedwetting, occasional stomach issues such as pain, and vomiting. Reinfection, even after successful treatment, is surprisingly common. 

The most widespread chronic human infection in the world is caused by intestinal parasites. Patients with weakened host defenses are vulnerable to opportunistic infections, which are brought on by infectious agents that do not typically cause illness in healthy people. In patients with compromised immune systems, these are recurrent. A person who is immunocompromised has a weakened or nonexistent immune system. Immunocompromised individuals, such as children, pregnant women, HIV (human immunodeficiency virus) patients, and cancer patients receiving chemotherapy or radiation therapy, have a reduced capacity to fight infections because of a malfunctioning immune response. Immunocompromised people can also result from other conditions like genetic disorders and some types of cancers. In spite of this, pinworm infection in immunocompromised people is still underreported and often neglected in clinical settings.1,2,3 

Reasons immunocompromised patients are at risk

Prolonged infection and compromised immunity

Some patients exhibit compromised immune defences that are insufficient to control Enterobius vermicularis (pinworm) infections. This immunodeficiency is often attributable to various comorbid conditions, including HIV, cancer chemotherapy, prolonged steroid use, diabetes, or immunosuppression following organ transplantation, among others. Prolonged or recurrent infection occurs due to impaired immune response, which results in all parasites to multiply or persist longer than usual.3,4 

Greater vulnerability among high-risk groups

Immunocompromised individuals experience a lower ability to effectively fight pathogens. This common vulnerability heightens their risk of contracting various infections, including parasitic organisms that are usually controlled by the immune systems in healthy individuals.3,5

Clinical indications in immunocompromised individuals

When someone's immune system is compromised, pinworm infections don't always follow the textbook presentation we typically see in healthy children. You might not always experience the characteristic itching around the anal area at night. Instead, these patients often deal with a whole range of gut problems, such as ongoing stomach pain, diarrhoea that just won't go away, or stubborn constipation. Here's the tricky part: doctors frequently chalk these symptoms up to whatever else the patient is going through, such as the severe side effects of chemotherapy or the potent immunosuppressive medications they are taking. However, the situation becomes more complex. There have been documented cases where these parasitic little worms actually infiltrate their way into the appendix. When that happens, you're looking at full-blown appendicitis, the kind that lands patients in for emergency surgery. It's one of those situations where a "simple" parasitic infection suddenly escalates into a surgical emergency.3,6,7 

In some rare reported cases, pinworms can migrate into the genital tract and cause vulvovaginitis, sometimes with secondary bacterial infections, especially in patients with weakened immune systems. These cases are often mistaken for common urinary tract or dermatological problems, unless specifically considered.8,9

Misdiagnosis is common because of these atypical and overlapping symptoms, especially in immunocompromised populations, where symptoms like pelvic discomfort, insomnia, or abdominal pain may be mistaken for more common conditions. In these situations, highlighting greater clinical suspicion for enterobiasis is crucial to avert a postponed diagnosis and unwanted treatments.

A real-world example

A recent case from 2024 illustrates just how tricky these infections can be. Two diabetic men aged 40 and 58 came to the hospital not with typical pinworm symptoms, but with abscesses and abnormal tissue connections in unusual places. Their poorly controlled diabetes had weakened their immune systems enough that what should have been a straightforward pinworm infection had spiraled into something much more serious. When doctors examined the infected tissue under a microscope, they found adult worms and eggs, confirming that pinworms were indeed the culprit behind these severe complications. Both patients needed albendazole treatment, followed by a second dose two weeks later. This case drives home an important point: when someone's immune system isn't functioning properly, even "simple" parasitic infections can take unexpected and serious turns.10

Challenges in diagnosis

Extensive asymptomatic situations

About 30-40% of pinworm infections are asymptomatic, meaning that patients do not show the typical symptoms like perianal itching. This merely indicates that the majority of these individuals are not aware of the risks they face daily. It is difficult to detect this subtle presentation, particularly in adults and immunocompromised people who might not get certain tests done until symptoms appear.11

Abnormal pinworm migration

The ectopic pinworm migration, though rare, may lead to a misleading clinical diagnosis. Rarely, pinworms may venture to odd places like the peritoneum, female genital tract, urinary tract, or even the appendix. In immunocompromised patients, where differential diagnoses are wide, these ectopic infections can be particularly deceptive as they can mimic other conditions, such as vaginitis or appendicitis, leading to delayed diagnosis and further complications.12

Misdiagnosis due to overlapping symptoms

Symptoms such as abdominal pain, insomnia, vulvar discomfort, or urinary issues often get attributed to the many other health challenges these patients are already facing. In immunocompromised individuals, doctors might reasonably assume these complaints stem from chemotherapy side effects, steroid-related complications, or opportunistic infections that commonly affect this population. This creates a diagnostic blind spot, where pinworm infection simply isn't considered as a potential cause. The result is that enterobiasis remains hidden in plain sight; the symptoms are there, but they're being explained by everything except the actual culprit.11,13

Diagnostic difficulties

The most reliable diagnostic tool so far is the scotch tape test, which involves pressing clear tape against the anal area first thing in the morning. Yet it's surprisingly underused in adult patients, even though it's far more accurate than stool tests for catching pinworm eggs. The reason is simple: these eggs rarely show up in stool samples, making fecal examination much less reliable.14

Moreover, although they are more accurate, advanced diagnostics like PCR and antigen-based assays are still mostly used in research settings and have not yet been implemented into clinical practice. A single negative test doesn't rule out infection because egg deposition is sporadic. Repeated sampling over several mornings is highly recommended for immunocompromised patients to improve detection sensitivity.15,16

Treatment challenges in immunocompromised patients

Treatment poses its own challenges in immunocompromised individuals once diagnosed. The standard therapies with medications such as albendazole, mebendazole, and pyrantel pamoate are generally deemed effective. These medications work by paralysing or inhibiting the worm’s glucose uptake, leading to eradication, but clinicians must carefully consider potential drug interactions. Albendazole and mebendazole, for instance, may interact with immunosuppressants, antiretrovirals, or chemotherapy medications, calling for careful observation.6,17

Due to weakened immunity and household exposure, reinfection and recurrence are a common phenomena in these patients. This typically requires numerous treatment courses, occasionally going beyond the conventional two-dose schedule. In addition to promoting hygienic practices such as frequent handwashing, bedding laundering, nail trimming, stringent follow-up is necessary to end the vicious cycle of transmission.1,2 

Treatment options and guidelines

Albendazole, mebendazole, and pyrantel pamoate are the commonly used anti-helminthic medications for enterobiasis, and when taken as directed, they are very effective. For instance, an in-depth article titled "The Diagnosis and Treatment of Pinworm Infection" highlights the importance of mebendazole as a first-line of treatment and the significant reduction in recurrence that occurs when doses are repeated at 14 and 28 days.12 

Drug interactions are especially crucial for patients with compromised immune systems. Given that albendazole is metabolized by the CYP450 enzyme system, taking it with certain immunosuppressants, antiretrovirals, or medications like corticosteroids may reduce its efficacy or increase its toxicity. The "Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole" is one example which, details interactions with medications like phenytoin, dexamethasone, and cimetidine.17

Compromised immunity in immunocompromised patients leads to the risk of reinfection and recurrence; hence stricter follow-up is essential as routine treatment regimens might not be enough. Regardless of the medication you receive, a second dose two weeks later is necessary to kill worms that hatched from eggs that weren't impacted by the first dose, according to guidelines.18 

Second or third doses, or longer therapies, may be particularly important in certain chronic cases. According to the PMC review, patients who experience recurrent infections may require treatment every 14 days for several weeks, along with treatment for every member of the household to avoid reinfection.12 

Hygiene and prevention in high-risk populations

When it comes to immunocompromised patients in hospitals or long-term care settings, infection control needs to be ramped up significantly. Pinworm eggs are surprisingly hardy; they can survive on bedding, clothing, and surfaces for weeks, spreading easily from person to person. This means regular disinfection isn't just helpful; it's absolutely necessary.19

Handwashing thoroughly and changing linens and underwear every day are essential at the household level. These simple steps can make the difference between clearing an infection and getting stuck in an endless reinfection cycle.18

Many people are unaware that caring for a single person in a home or care facility is frequently insufficient. Family members living together or patients in the same ward may all require treatment at the same time. The "treat everyone or treat no one" strategy actually makes sense in this particular situation.12

It is imperative that patients with compromised immune systems remain vigilant about these preventative measures. For someone with a compromised immune system, what might be a minor irritation can become a complicated and long-lasting infection. The important thing is to realize that in this situation, prevention is truly the best medicine.

Future pathways and research needs

Even though the pinworm infection is common, it is surprising to see the little research that has been conducted about its effect on immunocompromised adults. Most studies still center on children, leaving a significant knowledge gap about prevalence, complications, and outcomes in vulnerable adult populations.12

We clearly need clinical trials that examine whether extended or repeated treatment courses work better for immunocompromised patients. While doctors are already using these approaches based on clinical experience, we lack the rigorous evidence to know which regimens are most effective and safest for people with weakened immune systems.12,15

Perhaps most importantly, pinworm infections need to earn a spot in standard opportunistic infection protocols. If enterobiasis were included in the guidelines that doctors use when managing HIV patients, transplant recipients, or cancer patients on chemotherapy, it would automatically raise awareness and encourage routine screening.15

The bottom line is that we're treating a 21st-century patient population with diagnostic and treatment approaches that haven't evolved much since the mid-20th century. It's time for the research to catch up with the clinical reality.

Summary

What's often brushed off as a minor childhood nuisance can become a serious health concern when it strikes people with weakened immune systems. In immunocompromised patients, pinworm infections don't follow the usual playbook; they can involve higher parasite loads, present with unusual symptoms, and persist much longer than anyone expects.

We need to raise awareness among healthcare providers, improve our ability to diagnose infections early, and adapt treatment approaches that account for the higher risk of reinfection in this population. Strict hygiene practices aren't just helpful, they're essential, and they need to extend beyond individual households to encompass hospitals and long-term care facilities where vulnerable patients live and receive treatment.

The takeaway is clear: it's time to retire the notion that pinworms are just a childhood problem. For immunocompromised adults, these infections represent a real and potentially serious threat that deserves the same attention we give to other opportunistic infections.

References

  • CDC. Pinworm Infection. 2024 [cited 2025 Sep 11]. About pinworm infection. Available from: https://www.cdc.gov/pinworm/about/index.html
  • Mayo Clinic [Internet]. [cited 2025 Sep 11]. Pinworm infection-Pinworm infection - Symptoms & causes. Available from: https://www.mayoclinic.org/diseases-conditions/pinworm/symptoms-causes/syc-20376382
  • Al-Yousofi A, Yan Y, Al_Mekhlafi AM, Hezam K, Abouelnazar FA, Al-Rateb B, et al. Prevalence of intestinal parasites among immunocompromised patients, children, and adults in sana’a, yemen. Chieffi PP, editor. Journal of Tropical Medicine [Internet]. 2022 Jun 8 [cited 2025 Sep 11];2022:1–12. Available from: https://www.hindawi.com/journals/jtm/2022/5976640/
  • R K, Gopinathan A, Arumugam SL, Feliciana J H, KV L, D B, et al. Atypical manifestation of enterobius vermicularis infestation in adults: a report of a rare case. Cureus [Internet]. [cited 2025 Sep 11];16(10):e72074. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11580816/
  • Baiomy AMS, Mohamed KAAH, Ghannam MAM, Shahat SAAR, Al-Saadawy ASK. Opportunistic parasitic infections among immunocompromised Egyptian patients. J Egypt Soc Parasitol. 2010 Dec;40(3):797–808.
  • CDC. Pinworm Infection. 2024 [cited 2025 Sep 11]. Clinical overview of pinworm infection. Available from: https://www.cdc.gov/pinworm/hcp/clinical-overview/index.html
  • Tata RC, Abdelreheem M, Mercant Osuna A, Mangam S. Acute appendicitis due to enterobius vermicularis infestation: a case report. Cureus. 2024 Dec;16(12):e76535.
  • Davoodi L, Soleymani E, Oladi Z, Azar SS, Parandin F, Mizani A, et al. Vulvovaginitis due to Enterobius vermicularis in a girl and epidemic enterobiasis in her family. Clin Case Rep. 2024 May;12(5):e8902.
  • Siochou A, Birtsou H, Papazahariadou M. enterobius vermicularis infection of female genital tract. Int J Immunopathol Pharmacol [Internet]. 2008 Oct [cited 2025 Sep 11];21(4):1031–3. Available from: https://journals.sagepub.com/doi/10.1177/039463200802100429
  • Jayagandan, Kumaran,Rajkumari,, S Oudhaya, Nonika. Enterobius vermicularis in Immunocompromised Patients: A Case Report [Internet]. Available from: https://jcdr.net/articles/PDF/20240/70610_CE%5BRa1%5D_QC%28RD%29_F%28IS%29_PF1%28VD_SS_SHU%29_PFA%28VD_KM%29_PN%28SS%29.pdf
  • Enterobiasis (Pinworm infestation) clinical presentation: history, physical examination [Internet]. [cited 2025 Sep 11]. Available from: https://emedicine.medscape.com/article/997814-clinical
  • Wendt S, Trawinski H, Schubert S, C. Rodloff A, Mössner J, Lübbert C. The diagnosis and treatment of pinworm infection. Dtsch Arztebl Int [Internet]. 2019 Mar [cited 2025 Sep 11];116(13):213–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522669/
  • Cdc - dpdx - enterobiasis [Internet]. 2019 [cited 2025 Sep 11]. Available from: https://www.cdc.gov/dpdx/enterobiasis/index.html
  • CDC. Pinworm Infection. 2024 [cited 2025 Sep 11]. Diagnosing pinworms. Available from: https://www.cdc.gov/pinworm/diagnosing/index.html
  • Ummarino A, Caputo M, Tucci FA, Pezzicoli G, Piepoli A, Gentile A, et al. A PCR-based method for the diagnosis of Enterobius vermicularis in stool samples, specifically designed for clinical application. Front Microbiol [Internet]. 2022 Nov 17 [cited 2025 Sep 11];13:1028988. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712443/
  • Zelck UE, Bialek R, Weiß M. Molecular phylogenetic analysis of enterobius vermicularis and development of an 18s ribosomal dna-targeted diagnostic pcr▿. J Clin Microbiol [Internet]. 2011 Apr [cited 2025 Sep 11];49(4):1602–4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122864/
  • Pawluk SA, Roels CA, Wilby KJ, Ensom MHH. A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole. Clin Pharmacokinet. 2015 Apr;54(4):371–83.
  • Mayo Clinic [Internet]. [cited 2025 Sep 11]. Pinworm infection-Pinworm infection - Diagnosis & treatment. Available from: https://www.mayoclinic.org/diseases-conditions/pinworm/diagnosis-treatment/drc-20376386
  • CDC. Pinworm Infection. 2024 [cited 2025 Sep 11]. Preventing pinworm infection. Available from: https://www.cdc.gov/pinworm/prevention/index.html

Share

Shruti Patil

Bachelor of Pharmacy, Goa University
Data Analytics & Machine Learning certification, University of Toronto, Canada

Passionate about medical writing with a Bachelor of Pharmacy from Goa University and a Data Analytics & Machine Learning certification from the University of Toronto, Canada. Experienced as a research scientist in clinical research, I enjoy creating insightful articles for Klarity and am committed to growing my skills and advancing exponentially in this field.

arrow-right